ClinicalTrials.Veeva

Menu

A Problem Solving Intervention Involving Employees at Risk of Sick Leave Due to Common Mental Disorders (PRIME)

Karolinska Institute logo

Karolinska Institute

Status

Active, not recruiting

Conditions

Mental Disorders

Treatments

Behavioral: Care as usual
Behavioral: Problem solving intervention

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04975750
4-3084/2019

Details and patient eligibility

About

The overall aim of this randomized controlled trial is to evaluate the effectiveness of a problem-solving intervention for the prevention of sick leave among employees with early signs of CMDs. The intervention is delivered by first-line managers and a 30% reduction in sick leave days is expected in the experimental condition compared to treatment-as-usual, during the 12- months follow-up.

Full description

The overall aim of this randomized controlled trial is to evaluate the effectiveness of a problem-solving intervention for the prevention of sick leave among employees with early signs of CMDs. The intervention is delivered by first-line managers and a 30% reduction in sick leave days is expected in the experimental condition compared to treatment-as-usual, during the 12- months follow-up.

In an alongside process evaluation on the intervention's core activities, i.e. identification of early signs of CMDs, training of first-line managers in problem-solving and communication, we will:

  • evaluate whether and to what extent it was possible for the first-line managers to adhere to the intervention's protocol,
  • investigate the association between the intervention's core activities and number of sick leave days,
  • identify the facilitators and barriers to the intervention among first-line managers and employees and,
  • explore the first-line manager's organizational resources supporting their general managerial work.

The study will be conducted in private sector companies, among first-line managers and blue-collar workers. The outcomes will be evaluated on both cluster- and individual participant level.

Enrollment

170 patients

Sex

All

Ages

18 to 59 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • scoring with a cut-off ≥3 points on the GHQ-12, or a positive answer on the question on risk of SA, namely employee believes that he/she will receive a sickness certification due to stress, anxiety, or depression the following 12 months.
  • negative answer on the question on bullying, namely employee has not been exposed to bullying by his or her first line manager.
  • understand written and spoken Swedish.

Exclusion criteria

  • Ongoing sick leave (full- or part-time), leave of absence, pregnancy.
  • Sick leave ≥14 calendar days during the last 3 months due to CMD.
  • At the time for inclusion planned long-term absence during the coming year (for example parental leave, new job, retirement).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

170 participants in 2 patient groups

Problem solving intervention
Experimental group
Description:
Problem solving as developed by Nexu and colleguages. First-line managers are trained in the problem solving intervention (1 1/2 day). Thereafter, they apply the problem-solving in 2 - 5 meetings (about 30 - 45 min each) with employees at risk of future sick leave due to common mental disorders.
Treatment:
Behavioral: Problem solving intervention
Care as usual
Active Comparator group
Description:
First-line managers participate in a 3 hour lectur including a brief overview about worker health, occupational stress and the mismatch model and self-efficacy. Thereafter, they provide care-as-usual to employees at risk of future sick leave due to common mental disorders.
Treatment:
Behavioral: Care as usual

Trial contacts and locations

1

Loading...

Central trial contact

Elisabeth Björk-Brämberg, PhD; Bozana Arapovic-Johansson, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems